Harinder Gakhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Harinder Gakhar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Zdenek Klezl
Royal Derby Hospital
4 shared publications Rajendranath Bommireddy
Department of Trauma and Orthopaedics, Royal Derby Hospital, Derby, UK
3 shared publicationsDenis Calthorpe
Royal Derby Hospital
2 shared publicationsA. Dhillon
Spinal Unit, Division of Surgery, Royal Derby Hospital, Derby, DE223NE, UK
1 shared publicationAjay Sharma
Prince Charles Hospital, Merthyr Tydfil, UK
1 shared publicationGirish N. Swamy
Royal Derby Hospital
1 shared publication
Latest Publications
- 9 June 2015
- Published by Springer Nature in European Spine Journal
- Vol. 24 (10) , 2150-2155
Study investigating the role of skeletal muscle mass estimation in metastatic spinal cord compression
Age-related loss of functional muscle mass is associated with reduced functional ability and life expectancy. In disseminated cancer, age-related muscle loss may be exacerbated by cachexia and poor nutritional intake, increasing functional decline, morbidity and accelerate death. Patients with spinal metastases frequently present for decompressive surgery with decision to operate based upon functional assessment. A subjective assessment of physical performance has, however, been shown to be a poor indicator of life expectancy in these patients. We aimed to develop an objective measure based upon lean muscle mass to aid decision making, in these individuals, by investigating the association between muscle mass and 1-year survival. Muscle mass was calculated as total psoas area (TPA)/ vertebral body area (VBA), by two independent blinded doctors from CT images, acquired within 7 days of spinal metastases surgery, at the mid L3 vertebral level. Outcome at 1 year following surgery was recorded from a prospectively updated metastatic spinal cord compression database. 86 patients were followed for 1 year, with an overall mortality of 39.5 %. Mortality rates at 1 year were significantly high among patients in the lowest quartile of muscle mass, compared with those in the highest quartile (57.1 vs 23.8 %, p = 0.02). Death within 1 year in individuals with spinal metastases is related to lean muscle mass at presentation. Assessment of lean muscle mass may inform decision to operate in patients with spinal metastases.
- 9 June 2015
- Published by Springer Nature in European Spine Journal
- Vol. 24 (10) , 2150-2155
Study investigating the role of skeletal muscle mass estimation in metastatic spinal cord compression
Age-related loss of functional muscle mass is associated with reduced functional ability and life expectancy. In disseminated cancer, age-related muscle loss may be exacerbated by cachexia and poor nutritional intake, increasing functional decline, morbidity and accelerate death. Patients with spinal metastases frequently present for decompressive surgery with decision to operate based upon functional assessment. A subjective assessment of physical performance has, however, been shown to be a poor indicator of life expectancy in these patients. We aimed to develop an objective measure based upon lean muscle mass to aid decision making, in these individuals, by investigating the association between muscle mass and 1-year survival. Muscle mass was calculated as total psoas area (TPA)/ vertebral body area (VBA), by two independent blinded doctors from CT images, acquired within 7 days of spinal metastases surgery, at the mid L3 vertebral level. Outcome at 1 year following surgery was recorded from a prospectively updated metastatic spinal cord compression database. 86 patients were followed for 1 year, with an overall mortality of 39.5 %. Mortality rates at 1 year were significantly high among patients in the lowest quartile of muscle mass, compared with those in the highest quartile (57.1 vs 23.8 %, p = 0.02). Death within 1 year in individuals with spinal metastases is related to lean muscle mass at presentation. Assessment of lean muscle mass may inform decision to operate in patients with spinal metastases.
- Open Access
- 1 January 2013
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 7 (3) , 167-172
Role of Intraoperative Red Cell Salvage and Autologus Transfusion in Metastatic Spine Surgery: A Pilot Study and Review of Literature
Gakhar H, et al. Asian Spine J. 2013 Sep;7(3):167-172. http://dx.doi.org/10.4184/asj.2013.7.3.167
- 1 January 2013
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 7 (3) , 167-172
Open AccessRole of Intraoperative Red Cell Salvage and Autologus Transfusion in Metastatic Spine Surgery: A Pilot Study and Review of Literature
Gakhar H, et al. Asian Spine J. 2013 Sep;7(3):167-172. http://dx.doi.org/10.4184/asj.2013.7.3.167
- 31 December 2012
- Published by Elsevier in Injury Extra
- Vol. 43 (12) , 151-152
Previously unreported Monteggia type II-equivalent fracture of the olecranon: A proposed modification of the Letts classification
- 31 December 2012
- Published by Elsevier in Injury Extra
- Vol. 43 (12) , 151-152
Previously unreported Monteggia type II-equivalent fracture of the olecranon: A proposed modification of the Letts classification
- 17 August 2012
- Published by Springer Nature in European Spine Journal
- Vol. 22 (3) , 565-568
A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer
Predicted survival of a patient is the most important parameter that helps to guide the treatment of a patient with metastatic spinal cancer. We aimed to investigate the reliability of modified Tokuhashi score in the decision-making process in patients with metastatic spinal cancer. We performed a review of our prospectively collected Metastatic Cancer Database over a period of 4 years (2007–2010). Ninety consecutive patients who were treated for metastatic spinal cancer were enrolled. Data review included demographic details, source of primary cancer, duration of symptoms, location of metastases, calculated Karnofsky’s performance status, and calculated survival based on modified Tokuhashi score. We divided the patients into 3 groups. Group A included patients with expected survival less than 6 months. Group B included patients with expected survival between 6 and 12 months. Group C included patients whose expected survival was more than 12 months. We compared the calculated expected survival to the actual survival in all three groups with all patients following up to a minimum of 1 year or until death. Statistical analysis was done by Chi-square test and the Fisher Exact test. The survival prediction in group C was significantly accurate in 80.9 % patients (P = 0.027). However, in groups A and B, only 36.1 and 9.1 % patients survived, respectively, as per predicted. (P > 0.05). We can conclude from this study that, when used alone, modified Tokuhashi score may not be a reliable tool to predict survival in all patient groups.
- 17 August 2012
- Published by Springer Nature in European Spine Journal
- Vol. 22 (3) , 565-568
A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer
Predicted survival of a patient is the most important parameter that helps to guide the treatment of a patient with metastatic spinal cancer. We aimed to investigate the reliability of modified Tokuhashi score in the decision-making process in patients with metastatic spinal cancer. We performed a review of our prospectively collected Metastatic Cancer Database over a period of 4 years (2007–2010). Ninety consecutive patients who were treated for metastatic spinal cancer were enrolled. Data review included demographic details, source of primary cancer, duration of symptoms, location of metastases, calculated Karnofsky’s performance status, and calculated survival based on modified Tokuhashi score. We divided the patients into 3 groups. Group A included patients with expected survival less than 6 months. Group B included patients with expected survival between 6 and 12 months. Group C included patients whose expected survival was more than 12 months. We compared the calculated expected survival to the actual survival in all three groups with all patients following up to a minimum of 1 year or until death. Statistical analysis was done by Chi-square test and the Fisher Exact test. The survival prediction in group C was significantly accurate in 80.9 % patients (P = 0.027). However, in groups A and B, only 36.1 and 9.1 % patients survived, respectively, as per predicted. (P > 0.05). We can conclude from this study that, when used alone, modified Tokuhashi score may not be a reliable tool to predict survival in all patient groups.
- 19 July 2012
- Published by Springer Nature in European Spine Journal
- Vol. 22 (S3) , 346-349
Spinal subdural hematoma as a complication of spinal surgery: can it happen without dural tear?
Post spinal surgery subdural hematoma is a rare entity. This is a report of a case of acute post-operative spinal subdural hematoma, without any dural injury. The case was managed expectantly and went on to complete resolution of the hematoma and full clinical recovery.
- 19 July 2012
- Published by Springer Nature in European Spine Journal
- Vol. 22 (S3) , 346-349
Spinal subdural hematoma as a complication of spinal surgery: can it happen without dural tear?
Post spinal surgery subdural hematoma is a rare entity. This is a report of a case of acute post-operative spinal subdural hematoma, without any dural injury. The case was managed expectantly and went on to complete resolution of the hematoma and full clinical recovery.